*Based on self-reported member data on a Found program from members with no prior weight loss medication use, who reported weight loss of 12.1% in 6 months on compounded tirzepatide, as of April 2026
Mood improvements may result from better glycaemic control, weight loss, improved physical health, and enhanced self-esteem rather than direct effects on serotonin or other mood-regulating neurotransmitters
Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation
L-carnitine improved exercise tolerance and muscle strength while decreasing lactate production
In SURPASS-2, dizziness was listed among the commonly reported adverse events for both tirzepatide and semaglutide groups
GHK-Cu peptide may act upstream of both pathways, possibly by modulating copper-dependent enzymatic activity or gene regulatory networks